Glaucoma Open-angle
📧 Sign up to get email alerts when something new happens for Glaucoma Open-angle.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Clinical Study Evaluating the Efficacy and Safety of CID v2.2 in Glaucoma Surgery [NA]
This entry reports a clinical trial evaluating the efficacy and safety of CID v2.2 in glaucoma surgery. The study is sponsored by Ciliatech …
-
EMA approval · 2026-03-24EMA Authorised: Roclanda (Latanoprost;netarsudil mesilate) — Santen Oy
The European Medicines Agency has authorised Roclanda, a fixed-dose combination of latanoprost and netarsudil mesilate, for use in open-angl…
-
EMA approval · 2026-02-09EMA Authorised: Azopt (brinzolamide) — Novartis Europharm Limited
EMA authorised Azopt, brinzolamide 1% suspension, for open-angle glaucoma and ocular hypertension in the European Union. Novartis Europharm …
-
EMA approval · 2026-01-23EMA Authorised: Simbrinza (brinzolamide;brimonidine tartrate) — Novartis Europharm Limited
The EMA authorised Simbrinza, a fixed-dose combination of brinzolamide and brimonidine tartrate, for the treatment of ocular hypertension an…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Feasibility Clinical Evaluation of the Calibreye System [NA]
This feasibility clinical evaluation is studying the Calibreye System for open-angle glaucoma. The study is currently recruiting and sponsor…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-27Clinical Trial Update: Study of OMNI Surgical System and iStent for Eyes With OAG (Trident) [NA]
The clinical trial update indicates termination of the Trident study evaluating the OMNI Surgical System and iStent for open-angle glaucoma,…
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: GLAUcoma Diagnostic and Imaging Analysis (GLAUDIA) Study
GLAUDIA is a glaucoma diagnostic and imaging study sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS; the trial statu…
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: Study of a Novel Interposition Supraciliary Implant in Patients With Open Angle Glaucoma (SAFARI 2) [NA]
The SAFARI 2 trial evaluating a novel interposition supraciliary implant for open-angle glaucoma has been terminated.
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: Optimal Treatment Protocol for Selective Laser Trabeculoplasty - Repeat Trial [NA]
This clinical trial update describes a repeat study to optimize the treatment protocol for selective laser trabeculoplasty in glaucoma. The …
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: SCTSC Versus Trabeculectomy in Medically Uncontrolled Open-Angle Glaucoma in Pseudophakic Patients [NA]
A clinical trial is evaluating SCTSC versus trabeculectomy in pseudophakic patients with medically uncontrolled open-angle glaucoma and is c…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Evaluate Efficacy and Safety of PA5108 Ocular Implants in Primary Open Angle Glaucoma or Ocular Hypertension [Phase 2]
Phase 2 clinical trial investigating PA5108 ocular implant for primary open-angle glaucoma or ocular hypertension is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: To Compare the Efficacy and Safety of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes [Phase 3]
Phase 3 trial comparing Perrigo's glaucoma/ocular hypertension product to an FDA-approved comparator has completed, and results have been po…
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: GATT Versus Canaloplasty (GVC) [NA]
Clinical trial comparing GATT versus canaloplasty for open-angle glaucoma is currently recruiting at the Medical University of Bialystok.
-
EMA approval · 2025-01-27EMA Authorised: Izba (travoprost) — Novartis Europharm Limited
The European Medicines Agency authorised Izba, a travoprost eye drop by Novartis Europharm Limited, for ocular hypertension and open-angle g…
-
CLINICAL_TRIALS research · 2024-10-31Clinical Trial Update: Inflammatory Biomarkers in Ocular Surface in Primary Open Angle Glaucoma or Ocular Hypertension Under Topical Prostaglandins
This clinical trial investigates inflammatory biomarkers on the ocular surface in patients with open-angle glaucoma or ocular hypertension w…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Performance of the Travoprost Intraocular Implant [Phase 2]
Phase 2 trial results for the travoprost intraocular implant targeting open-angle glaucoma and ocular hypertension have been posted.
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Lamina Cribrosa Depth Change With Change in Eye Pressure [NA]
A Johns Hopkins University–led clinical trial (NCT03267849) evaluating lamina cribrosa depth changes with intraocular pressure changes in op…
-
CLINICAL_TRIALS trial_result · 2024-08-23Clinical Trial Update: How Much Does Reduced Dosing of Latanoprost and Dorzolamide-timolol Affect Pressure? [Phase 4]
A Phase 4 trial evaluated whether reduced dosing of latanoprost and dorzolamide-timolol affects intraocular pressure in glaucoma, and the st…
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: Efficacy of Citicoline Eye Drops 2% on Visual Field Preservation in Patients With Open Angle Glaucoma [Phase 3]
A Phase 3 clinical trial evaluating the efficacy of 2% citicoline eye drops for preserving the visual field in open-angle glaucoma is curren…
-
EMA approval · 2024-02-13EMA Authorised: Catiolanze (Latanoprost) — Santen Oy
EMA authorises Catiolanze (latanoprost) for glaucoma, open-angle, indicating market entry by Santen Oy.
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: Use of Methazolamide to Lower Intraocular Pressure [Phase 4]
Phase 4 trial update on methazolamide to lower intraocular pressure in open-angle glaucoma.
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Comparative Study of the Efficacy of Either Krytantek Ofteno PF® or Eliptic Ofteno PF® Plus Gaap Ofteno PF® for POAG or Ocular Hypertension. [Phase 4]
Phase 4 trial comparing two PF-formulation eye drops for open-angle glaucoma and ocular hypertension; the study has been terminated.
-
CLINICAL_TRIALS trial_result · 2023-09-26Clinical Trial Update: Clinical Study Comparing Two Models of a Travoprost Intraocular Implant [Phase 3]
Phase 3 clinical study comparing two models of a travoprost intraocular implant in glaucoma and ocular hypertension completed with results p…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Glaucoma Surgery Using the ViaLase Laser System [NA]
Clinical trial update for glaucoma surgery using the ViaLase laser system; the study is completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2022-12-13Clinical Trial Update: Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% to LUMIGAN® In The Treatment of Chronic Open-Angle Glaucoma [Phase 3]
Phase 3 bioequivalence study with clinical endpoints comparing Bimatoprost Ophthalmic Solution 0.01% to LUMIGAN in chronic open-angle glauco…